These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10486171)

  • 21. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination.
    Blesch A; Tuszynski MH
    J Comp Neurol; 2003 Dec; 467(3):403-17. PubMed ID: 14608602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery.
    Haase G; Pettmann B; Bordet T; Villa P; Vigne E; Schmalbruch H; Kahn A
    Ann Neurol; 1999 Mar; 45(3):296-304. PubMed ID: 10072043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
    Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease.
    Tornøe J; Torp M; Jørgensen JR; Emerich DF; Thanos C; Bintz B; Fjord-Larsen L; Wahlberg LU
    Restor Neurol Neurosci; 2012; 30(3):225-36. PubMed ID: 22426041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
    Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
    J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin.
    Hamilton JF; Morrison PF; Chen MY; Harvey-White J; Pernaute RS; Phillips H; Oldfield E; Bankiewicz KS
    Exp Neurol; 2001 Mar; 168(1):155-61. PubMed ID: 11170730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
    Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
    J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for Huntington's disease.
    Ramaswamy S; Kordower JH
    Neurobiol Dis; 2012 Nov; 48(2):243-54. PubMed ID: 22222669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotrophic factors in Huntington's disease.
    Alberch J; Pérez-Navarro E; Canals JM
    Prog Brain Res; 2004; 146():195-229. PubMed ID: 14699966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
    Bachoud-Lévi AC; Déglon N; Nguyen JP; Bloch J; Bourdet C; Winkel L; Rémy P; Goddard M; Lefaucheur JP; Brugières P; Baudic S; Cesaro P; Peschanski M; Aebischer P
    Hum Gene Ther; 2000 Aug; 11(12):1723-9. PubMed ID: 10954906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
    Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
    Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
    Emerich DF; Winn SR
    Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's disease.
    Rubinsztein DC; Leggo J; Chiano M; Korn S; Dodge A; Norbury G; Rosser E; Craufurd D
    Neurology; 1997 Sep; 49(3):890-2. PubMed ID: 9305364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
    Bloch J; Bachoud-Lévi AC; Déglon N; Lefaucheur JP; Winkel L; Palfi S; Nguyen JP; Bourdet C; Gaura V; Remy P; Brugières P; Boisse MF; Baudic S; Cesaro P; Hantraye P; Aebischer P; Peschanski M
    Hum Gene Ther; 2004 Oct; 15(10):968-75. PubMed ID: 15585112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRIB (NGF delivery) Cyto Therapeutics Inc.
    Cockett MI
    IDrugs; 1998 Jul; 1(3):362-7. PubMed ID: 18465562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
    Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
    Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of trophic factors to the primate brain.
    Kordower JH; Mufson EJ; Granholm AC; Hoffer B; Friden PM
    Exp Neurol; 1993 Nov; 124(1):21-30. PubMed ID: 8282075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.